Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	6-phosphofructokinase activity	PFKM PFKP	2.66e-05	3	60	2	GO:0003872
GeneOntologyMolecularFunction	fructose-6-phosphate binding	PFKM PFKP	8.83e-05	5	60	2	GO:0070095
GeneOntologyMolecularFunction	phosphofructokinase activity	PFKM PFKP	1.85e-04	7	60	2	GO:0008443
GeneOntologyBiologicalProcess	immunoglobulin production	IGKV1-16 IGKV1-5 IGKV1-6 CD28 IGKV1D-43 TRAV38-1 IGKV1D-8 IGKV4-1	5.34e-07	241	61	8	GO:0002377
GeneOntologyBiologicalProcess	production of molecular mediator of immune response	IGKV1-16 IGKV1-5 IGKV1-6 CD28 IGKV1D-43 TRAV38-1 IGKV1D-8 IGKV4-1	2.36e-05	403	61	8	GO:0002440
GeneOntologyBiologicalProcess	adaptive immune response	IGKV1-16 IGKV1-5 IGKV1-6 PPP3CB CD28 JAG1 IGKV1D-43 TRAV38-1 IGKV1D-8 IGKV4-1 CFHR4	3.04e-05	838	61	11	GO:0002250
GeneOntologyCellularComponent	immunoglobulin complex	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-43 IGKV1D-8 IGKV4-1	1.17e-05	166	64	6	GO:0019814
GeneOntologyCellularComponent	6-phosphofructokinase complex	PFKM PFKP	2.76e-05	3	64	2	GO:0005945
GeneOntologyCellularComponent	outer dynein arm	DNAI1 DNAH9	5.97e-04	12	64	2	GO:0036157
GeneOntologyCellularComponent	dynein complex	DNAI1 DYNC2H1 DNAH9	6.07e-04	54	64	3	GO:0030286
Domain	PHOSPHOFRUCTOKINASE	PFKM PFKP	2.84e-05	3	58	2	PS00433
Domain	6-Pfructokinase_euk	PFKM PFKP	2.84e-05	3	58	2	IPR009161
Domain	Phosphofructokinase_CS	PFKM PFKP	2.84e-05	3	58	2	IPR015912
Domain	PFK	PFKM PFKP	2.84e-05	3	58	2	PF00365
Domain	ATP_PFK	PFKM PFKP	2.84e-05	3	58	2	IPR022953
Domain	Phosphofructokinase_dom	PFKM PFKP	2.84e-05	3	58	2	IPR000023
Domain	DHC_N1	DYNC2H1 DNAH9	2.62e-04	8	58	2	PF08385
Domain	Dynein_heavy_dom-1	DYNC2H1 DNAH9	2.62e-04	8	58	2	IPR013594
Domain	ARM-type_fold	GBF1 PIK3C2G NBEAL1 CUL9 PSMD1 XPO1	6.26e-04	339	58	6	IPR016024
Domain	Dynein_heavy_chain_D4_dom	DYNC2H1 DNAH9	8.42e-04	14	58	2	IPR024317
Domain	Dynein_HC_stalk	DYNC2H1 DNAH9	8.42e-04	14	58	2	IPR024743
Domain	Dynein_heavy_dom-2	DYNC2H1 DNAH9	8.42e-04	14	58	2	IPR013602
Domain	DHC_N2	DYNC2H1 DNAH9	8.42e-04	14	58	2	PF08393
Domain	MT	DYNC2H1 DNAH9	8.42e-04	14	58	2	PF12777
Domain	AAA_8	DYNC2H1 DNAH9	8.42e-04	14	58	2	PF12780
Domain	ATPase_dyneun-rel_AAA	DYNC2H1 DNAH9	8.42e-04	14	58	2	IPR011704
Domain	AAA_5	DYNC2H1 DNAH9	8.42e-04	14	58	2	PF07728
Domain	EGF_extracell	TENM3 JAG1 LRP1B	8.58e-04	60	58	3	IPR013111
Domain	EGF_2	TENM3 JAG1 LRP1B	8.58e-04	60	58	3	PF07974
Domain	DHC_fam	DYNC2H1 DNAH9	9.70e-04	15	58	2	IPR026983
Domain	Dynein_heavy_dom	DYNC2H1 DNAH9	9.70e-04	15	58	2	IPR004273
Domain	Dynein_heavy	DYNC2H1 DNAH9	9.70e-04	15	58	2	PF03028
Domain	CarboxyPept-like_regulatory	TENM3 CILP	1.25e-03	17	58	2	IPR008969
Domain	NA_NEUROTRAN_SYMP_2	SLC6A3 SLC6A11	1.40e-03	18	58	2	PS00754
Domain	SNF	SLC6A3 SLC6A11	1.57e-03	19	58	2	PF00209
Domain	NA_NEUROTRAN_SYMP_1	SLC6A3 SLC6A11	1.57e-03	19	58	2	PS00610
Domain	NA_NEUROTRAN_SYMP_3	SLC6A3 SLC6A11	1.57e-03	19	58	2	PS50267
Domain	Na/ntran_symport	SLC6A3 SLC6A11	1.57e-03	19	58	2	IPR000175
Domain	IGv	IGKV1-5 CD28 IGKV4-1	1.64e-03	75	58	3	SM00406
Domain	-	ATP11B ATP13A5	4.43e-03	32	58	2	3.40.1110.10
Domain	-	ATP11B ATP13A5	4.43e-03	32	58	2	2.70.150.10
Domain	ATPase_P-typ_cyto_domN	ATP11B ATP13A5	5.28e-03	35	58	2	IPR023299
Domain	P_typ_ATPase	ATP11B ATP13A5	5.58e-03	36	58	2	IPR001757
Domain	ATPase_P-typ_P_site	ATP11B ATP13A5	5.58e-03	36	58	2	IPR018303
Domain	ATPASE_E1_E2	ATP11B ATP13A5	5.58e-03	36	58	2	PS00154
Domain	ATPase_P-typ_transduc_dom_A	ATP11B ATP13A5	5.89e-03	37	58	2	IPR008250
Domain	E1-E2_ATPase	ATP11B ATP13A5	5.89e-03	37	58	2	PF00122
Domain	-	PRMT5 METTL14 DNMT3A	6.17e-03	120	58	3	3.40.50.150
Domain	SAM-dependent_MTases	PRMT5 METTL14 DNMT3A	6.46e-03	122	58	3	IPR029063
Domain	-	TENM3 LRP1B	6.52e-03	39	58	2	2.120.10.30
Pathway	REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION	IGKV1-16 IGKV1-5 PPP3CB IGKV1D-16 IGKV4-1	1.28e-05	86	50	5	M27206
Pathway	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR	IGKV1-16 IGKV1-5 PPP3CB PSMD1 IGKV1D-16 IGKV4-1	2.52e-05	166	50	6	M608
Pathway	REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING	IGKV1-16 IGKV1-5 PPP3CB PSMD1 IGKV1D-16 IGKV4-1	4.77e-05	186	50	6	M27175
Pathway	REACTOME_COMPLEMENT_CASCADE	IGKV1-16 IGKV1-5 IGKV1D-16 IGKV4-1 CFHR4	5.23e-05	115	50	5	M19752
Pathway	REACTOME_CD22_MEDIATED_BCR_REGULATION	IGKV1-16 IGKV1-5 IGKV1D-16 IGKV4-1	6.30e-05	61	50	4	M27581
Pathway	BIOCARTA_PTDINS_PATHWAY	JAG1 PFKM PFKP	7.07e-05	23	50	3	M8809
Pathway	REACTOME_FCGR_ACTIVATION	IGKV1-16 IGKV1-5 IGKV1D-16 IGKV4-1	1.02e-04	69	50	4	M27108
Pathway	REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA	IGKV1-16 IGKV1-5 IGKV1D-16 IGKV4-1	1.02e-04	69	50	4	M27150
Pathway	KEGG_GALACTOSE_METABOLISM	MGAM PFKM PFKP	1.03e-04	26	50	3	M4377
Pathway	REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS	IGKV1-16 IGKV1-5 IGKV1D-16 IGKV4-1	1.14e-04	71	50	4	M1078
Pathway	REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION	IGKV1-16 IGKV1-5 IGKV1D-16 IGKV4-1	1.14e-04	71	50	4	M27203
Pathway	REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION	IGKV1-16 IGKV1-5 PSMD1 IGKV1D-16 IGKV4-1	1.16e-04	136	50	5	M27207
Pathway	REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT	IGKV1-16 IGKV1-5 IGKV1D-16 IGKV4-1	1.82e-04	80	50	4	M6121
Pathway	REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS	IGKV1-16 IGKV1-5 IGKV1D-16 IGKV4-1	2.00e-04	82	50	4	M27110
Pathway	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS	IGKV1-16 IGKV1-5 IGKV1D-16 IGKV4-1	2.40e-04	86	50	4	M601
Pathway	REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION	IGKV1-16 IGKV1-5 IGKV1D-16 IGKV4-1	2.51e-04	87	50	4	M27205
Pathway	REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS	IGKV1-16 IGKV1-5 IGKV1D-16 IGKV4-1	3.52e-04	95	50	4	M29842
Pathway	REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS	IGKV1-16 IGKV1-5 IGKV1D-16 IGKV4-1	3.96e-04	98	50	4	M27152
Pathway	REACTOME_PARASITE_INFECTION	IGKV1-16 IGKV1-5 IGKV1D-16 IGKV4-1	7.49e-04	116	50	4	M29843
Pubmed	Characteristics of the immunoglobulin Vkappa genes, pseudogenes, relics and orphons in the mouse genome.	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-43 IGKV1D-8 IGKV4-1	1.28e-12	20	65	6	10427970
Pubmed	Variation in the crossover point of kappa immunoglobulin gene V-J recombination: evidence from a cryptic gene.	IGKV1-16 IGKV1-5 IGKV1-6	5.19e-07	9	65	3	6777049
Pubmed	Amino acid sequence of the variable region of M149 mouse myeloma light chain: comparison with the nucleotide sequence of K2 and K3 clones.	IGKV1-5 IGKV1D-43 IGKV1D-8	1.02e-06	11	65	3	6795447
Pubmed	Multiple related immunoglobulin variable-region genes identified by cloning and sequence analysis.	IGKV1-5 IGKV1D-43 IGKV1D-8	1.02e-06	11	65	3	279004
Pubmed	Organization and complete sequence of identical embryonic and plasmacytoma kappa V-region genes.	IGKV1-5 IGKV1D-43 IGKV1D-8	1.02e-06	11	65	3	6767723
Pubmed	Structure and implied functions of truncated B-cell receptor mRNAs in early embryo and adult mesenchymal stem cells: Cdelta replaces Cmu in mu heavy chain-deficient mice.	IGKV1-16 IGKV1-5 IGKV1-6	3.43e-06	16	65	3	17124007
Pubmed	Cloning of human muscle phosphofructokinase cDNA.	PFKM PFKP	3.44e-06	2	65	2	2822475
Pubmed	Chimeric phosphofructokinases involving exchange of the N- and C-terminal halves of mammalian isozymes: implications for ligand binding sites.	PFKM PFKP	3.44e-06	2	65	2	17544406
Pubmed	Structures of human phosphofructokinase-1 and atomic basis of cancer-associated mutations.	PFKM PFKP	3.44e-06	2	65	2	25985179
Pubmed	Human myeloperoxidase in innate and acquired immunity.	IGKV1-5 IGKV1D-43 IGKV1D-8	4.98e-06	18	65	3	20399194
Pubmed	Biochemical and transcript level differences between the three human phosphofructokinases show optimisation of each isoform for specific metabolic niches.	PFKM PFKP	1.03e-05	3	65	2	33141153
Pubmed	Phosphofructokinase (PFK) isozymes in man. I. Studies of adult human tissues.	PFKM PFKP	1.03e-05	3	65	2	156693
Pubmed	Protein arginine methyltransferase 5-mediated epigenetic silencing of IRX1 contributes to tumorigenicity and metastasis of gastric cancer.	PRMT5 DNMT3A	1.03e-05	3	65	2	29802960
Pubmed	Functional expression of human mutant phosphofructokinase in yeast: genetic defects in French Canadian and Swiss patients with phosphofructokinase deficiency.	PFKM PFKP	1.03e-05	3	65	2	7825568
Pubmed	Isozymes of human phosphofructokinase in blood cells and cultured cell lines: molecular and genetic evidence for a trigenic system.	PFKM PFKP	1.03e-05	3	65	2	6451249
Pubmed	Isozymes of human phosphofructokinase: identification and subunit structural characterization of a new system.	PFKM PFKP	1.03e-05	3	65	2	6444721
Pubmed	Mislocalization of DNAH5 and DNAH9 in respiratory cells from patients with primary ciliary dyskinesia.	DNAI1 DNAH9	1.03e-05	3	65	2	15750039
Pubmed	Genomic organization, 5'flanking region and tissue-specific expression of mouse phosphofructokinase C gene.	PFKM PFKP	1.03e-05	3	65	2	11137296
Pubmed	Characterization of the enzymatic defect in late-onset muscle phosphofructokinase deficiency. New subtype of glycogen storage disease type VII.	PFKM PFKP	1.03e-05	3	65	2	2960695
Pubmed	Phosphofructokinase isozyme expression during myoblast differentiation.	PFKM PFKP	1.03e-05	3	65	2	2521854
Pubmed	IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes.	IGKV1-16 IGKV1-5 IGKV1-6 IGKV4-1	1.36e-05	77	65	4	15608191
Pubmed	Evolution of immunoglobulin V genes: evidence indicating that recently duplicated human V kappa sequences have diverged by gene conversion.	IGKV1-16 IGKV1D-16	2.06e-05	4	65	2	6402305
Pubmed	Composite human VK genes and a model of their evolution.	IGKV1-5 IGKV1D-8	2.06e-05	4	65	2	6087279
Pubmed	PRMT5-mediated methylation of histone H4R3 recruits DNMT3A, coupling histone and DNA methylation in gene silencing.	PRMT5 DNMT3A	2.06e-05	4	65	2	19234465
Pubmed	Nuclear export of phosphorylated C/EBPbeta mediates the inhibition of albumin expression by TNF-alpha.	CEBPB XPO1	2.06e-05	4	65	2	11726507
Pubmed	DNAI2 mutations cause primary ciliary dyskinesia with defects in the outer dynein arm.	DNAI1 DNAH9	2.06e-05	4	65	2	18950741
Pubmed	GABA uptake transporters support dopamine release in dorsal striatum with maladaptive downregulation in a parkinsonism model.	SLC6A3 SLC6A11	3.43e-05	5	65	2	33009395
Pubmed	Development of monoclonal antibodies against GBF1 and their use in studying its functions.	GBF1 CEBPB	3.43e-05	5	65	2	16318580
Pubmed	The establishment of rotational polarity in the airway and ependymal cilia: analysis with a novel cilium motility mutant mouse.	DNAI1 DNAH9	3.43e-05	5	65	2	23525783
Pubmed	PDGF signalling in the dermis and in dermal condensates is dispensable for hair follicle induction and formation.	EDAR ITGA8	3.43e-05	5	65	2	25708924
Pubmed	Evolutionary dynamics of the human immunoglobulin kappa locus and the germline repertoire of the Vkappa genes.	IGKV1D-43 IGKV1D-16 IGKV1D-8	4.26e-05	36	65	3	11298326
Pubmed	Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis.	PFKM PFKP	5.13e-05	6	65	2	29038421
Pubmed	Proteomic identification of brain proteins that interact with dynein light chain LC8.	PFKM PFKP DNMT3A	6.79e-05	42	65	3	14760703
Pubmed	FMRP Modulates Neural Differentiation through m6A-Dependent mRNA Nuclear Export.	XPO1 METTL14	7.18e-05	7	65	2	31340148
Pubmed	Identification of intervals on chromosomes 1, 3, and 13 linked to the development of lupus in BXSB mice.	CD28 CFHR4	7.18e-05	7	65	2	10693874
Pubmed	Diverse alternative back-splicing and alternative splicing landscape of circular RNAs.	XPO1 ZFX	9.56e-05	8	65	2	27365365
Pubmed	A regulatory circuit that involves HR23B and HDAC6 governs the biological response to HDAC inhibitors.	GBF1 PSMD1 PFKP	1.15e-04	50	65	3	23703321
Pubmed	RAD21 cooperates with pluripotency transcription factors in the maintenance of embryonic stem cell identity.	PRMT5 PSMD1 PFKP DNMT3A	1.65e-04	146	65	4	21589869
Pubmed	Progesterone induced Warburg effect in HEK293 cells is associated with post-translational modifications and proteasomal degradation of progesterone receptor membrane component 1.	PTPRS PFKM PFKP	1.79e-04	58	65	3	31067491
Pubmed	Ubiquitin ligase TRIM71 suppresses ovarian tumorigenesis by degrading mutant p53.	PRMT5 CUL9	1.87e-04	11	65	2	31570706
Pubmed	Pih1d3 is required for cytoplasmic preassembly of axonemal dynein in mouse sperm.	DNAI1 DNAH9	1.87e-04	11	65	2	24421334
Pubmed	Conserved expression of ultra-conserved noncoding RNA in mammalian nervous system.	SETD5 NPAS3 XPO1	1.98e-04	60	65	3	29055695
Pubmed	ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.	PRMT5 EIF3L PSMD1 XPO1 PFKM PFKP	1.99e-04	451	65	6	36168627
Pubmed	Recruitment of phosphatidylinositol 3-kinase to CD28 inhibits HIV transcription by a Tat-dependent mechanism.	PIK3C2G CD28	2.24e-04	12	65	2	12077252
Pubmed	Sall1 balances self-renewal and differentiation of renal progenitor cells.	JAG1 ITGA8 CFHR4	2.74e-04	67	65	3	24550112
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	CEP350 GBF1 NBEAL1 PSMD1 XPO1 PFKP DNMT3A	2.99e-04	689	65	7	36543142
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	CACNA2D1 ATP11B PTPRS CUL9 PSMD1	3.04e-04	313	65	5	38270169
Pubmed	Extensive alternative splicing transitions during postnatal skeletal muscle development are required for calcium handling functions.	CACNA2D1 PPP3CB	3.08e-04	14	65	2	28826478
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CEP350 ZNF462 GBF1 DYNC2H1 PLEKHG3 N4BP2	3.20e-04	493	65	6	15368895
Pubmed	CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.	PRMT5 EIF3L PSMD1 XPO1 PFKM PFKP	3.24e-04	494	65	6	26831064
Pubmed	A high-resolution molecular atlas of the fetal mouse lower urogenital tract.	EDAR JAG1 DNMT3A	3.82e-04	75	65	3	21905163
Pubmed	CRL4B promotes tumorigenesis by coordinating with SUV39H1/HP1/DNMT3A in DNA methylation-based epigenetic silencing.	PRMT5 DNMT3A	4.06e-04	16	65	2	24292684
Pubmed	Role of topoisomerase IIbeta in the expression of developmentally regulated genes.	CACNA2D1 TENM3	4.06e-04	16	65	2	16923961
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	TENM3 DYNC2H1 PRMT5 EIF3L	4.24e-04	187	65	4	26460568
Pubmed	Physiogenomic analysis of statin-treated patients: domain-specific counter effects within the ACACB gene on low-density lipoprotein cholesterol?	SLC6A3 PIK3C2G PFKM PFKP	4.68e-04	192	65	4	20602615
Pubmed	Rewiring of embryonic glucose metabolism via suppression of PFK-1 and aldolase during mouse chorioallantoic branching.	PFKM PFKP	5.16e-04	18	65	2	28049690
Pubmed	Stem cells. m6A mRNA methylation facilitates resolution of naïve pluripotency toward differentiation.	METTL14 DNMT3A	5.16e-04	18	65	2	25569111
Pubmed	Chromatin remodeling enzyme Brg1 is required for mouse lens fiber cell terminal differentiation and its denucleation.	JAG1 DNMT3A	5.76e-04	19	65	2	21118511
Pubmed	The repertoire of solute carriers of family 6: identification of new human and rodent genes.	SLC6A3 SLC6A11	7.06e-04	21	65	2	16125675
Pubmed	METTL3-mediated m6A modification is required for cerebellar development.	JAG1 METTL14	7.06e-04	21	65	2	29879109
Pubmed	Nonmuscle Myosin II Regulates the Morphogenesis of Metanephric Mesenchyme-Derived Immature Nephrons.	JAG1 ITGA8	7.06e-04	21	65	2	25168025
Pubmed	DNA Methyltransferase 1 Controls Nephron Progenitor Cell Renewal and Differentiation.	JAG1 DNMT3A	7.76e-04	22	65	2	30518531
Pubmed	PRDM16 expression and function in mammalian cochlear development.	JAG1 ITGA8	8.48e-04	23	65	2	35451126
Pubmed	METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis.	PRMT5 EIF3L PSMD1 METTL14	9.35e-04	231	65	4	36597993
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	AREL1 ZFYVE26 DNAH9	9.92e-04	104	65	3	9205841
Pubmed	Single Cell and Open Chromatin Analysis Reveals Molecular Origin of Epidermal Cells of the Skin.	EDAR JAG1	1.00e-03	25	65	2	30220568
Pubmed	Cilia gene mutations cause atrioventricular septal defects by multiple mechanisms.	DNAI1 DYNC2H1	1.00e-03	25	65	2	27340223
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CEP350 GBF1 SASH1 PLEKHG3 N4BP2 PRMT5 PFKP	1.11e-03	861	65	7	36931259
Pubmed	Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics.	PRMT5 EIF3L PSMD1 XPO1 PFKM	1.17e-03	422	65	5	27342126
Pubmed	Deterministic and stochastic allele specific gene expression in single mouse blastomeres.	ATP11B JAG1 PFKP ZFX DNMT3A	1.19e-03	424	65	5	21731673
Pubmed	Identification of FBXO25-interacting proteins using an integrated proteomics approach.	PRMT5 XPO1 PFKP	1.23e-03	112	65	3	20473970
Pubmed	LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells.	LY6G5B CEP350 PPP3CB CILP N4BP2 CUL9	1.24e-03	639	65	6	23443559
Pubmed	TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphoma.	EIF3L XPO1	1.26e-03	28	65	2	29653964
Pubmed	Proteomic and Biochemical Comparison of the Cellular Interaction Partners of Human VPS33A and VPS33B.	CEP350 GBF1 EIF3L PFKP	1.27e-03	251	65	4	29778605
Pubmed	Spatiotemporal Analysis of a Glycolytic Activity Gradient Linked to Mouse Embryo Mesoderm Development.	MGAM PFKM PFKP	1.29e-03	114	65	3	28245920
Pubmed	Dynamic MAPK/ERK Activity Sustains Nephron Progenitors through Niche Regulation and Primes Precursors for Differentiation.	JAG1 ITGA8	1.35e-03	29	65	2	30220628
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	PRMT5 EIF3L CUL9 PSMD1 XPO1 PFKP	1.38e-03	653	65	6	22586326
Pubmed	Physiogenomic comparison of edema and BMI in patients receiving rosiglitazone or pioglitazone.	PIK3C2G PFKM PFKP	1.39e-03	117	65	3	18996102
Pubmed	Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation.	PRMT5 EIF3L PSMD1 XPO1	1.40e-03	258	65	4	21081666
Pubmed	p63 regulates multiple signalling pathways required for ectodermal organogenesis and differentiation.	EDAR JAG1	1.45e-03	30	65	2	16524929
Pubmed	USP14 is a deubiquitinase for Ku70 and critical determinant of non-homologous end joining repair in autophagy and PTEN-deficient cells.	PSMD1 XPO1	1.45e-03	30	65	2	31740976
Pubmed	Targeting the p300/NONO axis sensitizes melanoma cells to BRAF inhibitors.	PRMT5 PFKM	1.45e-03	30	65	2	34017080
Pubmed	C16orf72/HAPSTR1 is a molecular rheostat in an integrated network of stress response pathways.	EIF3L PSMD1 XPO1	1.46e-03	119	65	3	35776542
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	GBF1 PPP3CB PRMT5 EIF3L PSMD1 XPO1 ERI1 PFKM PFKP	1.48e-03	1455	65	9	22863883
Pubmed	miR-218 Promotes Dopaminergic Differentiation and Controls Neuron Excitability and Neurotransmitter Release through the Regulation of a Synaptic-Related Genes Network.	SLC6A3 DNMT3A	1.54e-03	31	65	2	37816598
Pubmed	A genome-wide association study provides evidence for association of chromosome 8p23 (MYP10) and 10q21.1 (MYP15) with high myopia in the French Population.	ERI1 DNAH9	1.65e-03	32	65	2	23049088
Pubmed	Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.	PRMT5 PSMD1 XPO1 PFKP	1.70e-03	272	65	4	31010829
Pubmed	Distinct roles and regulations for HoxD genes in metanephric kidney development.	JAG1 ITGA8	1.75e-03	33	65	2	18159948
Pubmed	Roles of HIV-1 auxiliary proteins in viral pathogenesis and host-pathogen interactions.	CD28 XPO1	1.75e-03	33	65	2	16354571
Pubmed	Genome-wide association study on dimethylarginines reveals novel AGXT2 variants associated with heart rate variability but not with overall mortality.	CACNA2D1 LRP1B	1.75e-03	33	65	2	24159190
Pubmed	Genome-wide association study of smoking behaviours among Bangladeshi adults.	SASH1 TENM3	1.86e-03	34	65	2	24665060
Pubmed	Negative regulation of Shh levels by Kras and Fgfr2 during hair follicle development.	EDAR JAG1	1.86e-03	34	65	2	23123965
Interaction	DEFB135 interactions	CACNA2D1 ITGA8 LRP1B CEMIP2	7.80e-06	42	61	4	int:DEFB135
Interaction	CLU interactions	CEBPB TENM3 PTPRS ITGA8 XPO1 LRP1B METTL14	8.99e-06	245	61	7	int:CLU
Cytoband	2p12	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-43 IGKV1D-16 IGKV1D-8 IGKV4-1	4.00e-10	117	66	7	2p12
Cytoband	Ensembl 112 genes in cytogenetic band chr2p11	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-43 IGKV1D-16 IGKV1D-8 IGKV4-1	2.59e-08	213	66	7	chr2p11
Cytoband	3p25.3	SLC6A11 SETD5	1.94e-03	45	66	2	3p25.3
GeneFamily	Immunoglobulin kappa locus at 2p11.2	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-43 IGKV1D-16 IGKV1D-8 IGKV4-1	4.94e-09	83	54	7	351
GeneFamily	Dyneins, axonemal	DNAI1 DNAH9	1.16e-03	17	54	2	536
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3	ZNF462 ATP11B GPR50 DYNC2H1 AASDH CEMIP2 ZFX	2.55e-05	314	59	7	Facebase_RNAseq_e9.5_Mandibular Arch_2500_K3
ToppCell	10x5'-GI_large-bowel\|World / Manually curated celltypes from each tissue	IGKV1-16 IGKV1-5 IGKV1-6 ITGA8 IGKV1D-16 IGKV1D-8 IGKV4-1	5.78e-09	168	66	7	1290c909655bc37f6b8bf216d18127a21b99e9c0
ToppCell	Control-Lymphoid-B_Plasma\|Control / Disease state, Lineage and Cell class	IGKV1-16 IGKV1-5 ITGA8 IGKV1D-43 IGKV1D-16 IGKV1D-8 IGKV4-1	6.80e-09	172	66	7	61e33836b8cb0f347f3e699eb587a37073b6fa4c
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-43 IGKV1D-16 IGKV1D-8 IGKV4-1	1.35e-08	190	66	7	79ee6d10dfbb775da149a1104da5823cf63bbb46
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-43 IGKV1D-16 IGKV1D-8 IGKV4-1	1.35e-08	190	66	7	18762ce78ed0b206ade19e1c8ff76a2647489f68
ToppCell	5'-Adult-LargeIntestine-Hematopoietic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-43 IGKV1D-16 IGKV1D-8 IGKV4-1	1.40e-08	191	66	7	d1d30279ed4612b4f62c225d9eabf0b8a7a09d11
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-43 IGKV1D-16 IGKV1D-8 IGKV4-1	1.51e-08	193	66	7	34f6c13884fdf7f8a87f942fcb36a58cfac3f65d
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-43 IGKV1D-16 IGKV1D-8 IGKV4-1	1.56e-08	194	66	7	6ef4aeb8d8e35e4df58ff2a8256caa2113291de9
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	NLRP11 IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-43 IGKV1D-8 IGKV4-1	1.56e-08	194	66	7	a4a70369541876e1192df8828b63e3d1746ae3d9
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-43 IGKV1D-16 IGKV1D-8 IGKV4-1	1.62e-08	195	66	7	f3f7f1a77a1edd2b50a8211c76fe289738eb04cf
ToppCell	Biopsy_IPF-Immune-Plasma_cells\|Biopsy_IPF / Sample group, Lineage and Cell type	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-43 IGKV1D-16 IGKV1D-8 IGKV4-1	1.68e-08	196	66	7	a1b6a8000b86efcb07843998aa3a49bb1f54bcda
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	NLRP11 IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-16 IGKV1D-8 IGKV4-1	1.68e-08	196	66	7	fec21383435779bf4c632decd3d29c6ca7baebfb
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-43 IGKV1D-16 IGKV1D-8 IGKV4-1	1.74e-08	197	66	7	9fe1b757f76c2d43d39aa9ac500eaba98723985c
ToppCell	10x5'-blood-Lymphocytic_B_plasma-Plasma_cells\|blood / Manually curated celltypes from each tissue	IGKV1-16 IGKV1-5 IGKV1-6 ITGA8 IGKV1D-43 IGKV4-1	8.49e-08	147	66	6	58089378fac1743ce99dc4f1bd7b5253a927f050
ToppCell	10x5'-blood-Lymphocytic_B_plasma\|blood / Manually curated celltypes from each tissue	IGKV1-16 IGKV1-5 IGKV1-6 ITGA8 IGKV1D-43 IGKV4-1	9.57e-08	150	66	6	6bab0a8bf78ed7de9e1b67ede7496488f80f4863
ToppCell	390C-Lymphocytic-Plasma_cell-\|390C / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-5 IGKV1-6 IGKV1D-43 IGKV1D-16 IGKV1D-8 IGKV4-1	1.21e-07	156	66	6	4f92ca30755430db44402afc603d1ecd8bfc3617
ToppCell	390C-Lymphocytic-Plasma_cell\|390C / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-5 IGKV1-6 IGKV1D-43 IGKV1D-16 IGKV1D-8 IGKV4-1	1.21e-07	156	66	6	0de2fc695bd5f8d4633c514f71ea941c88137bac
ToppCell	normal_Lung-B_lymphocytes-MALT_B_cells\|normal_Lung / Location, Cell class and cell subclass	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-43 IGKV1D-8 IGKV4-1	1.35e-07	159	66	6	fbd0131b66f4267f7b0d6c3ad874ad097b859074
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-5 IGKV1-6 IGKV1D-43 IGKV1D-8 LRP1B IGKV4-1	1.51e-07	162	66	6	b46158e260bd2f35702cec73e3b035e8e9ec4469
ToppCell	metastatic_Brain-B_lymphocytes-Plasma_cells\|metastatic_Brain / Location, Cell class and cell subclass	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-43 IGKV1D-8 IGKV4-1	2.01e-07	170	66	6	53634da9e9c72f6400639954c286c6e38ea5a188
ToppCell	IPF-Lymphoid-B_Plasma\|IPF / Disease state, Lineage and Cell class	IGKV1-5 IGKV1-6 IGKV1D-43 IGKV1D-16 IGKV1D-8 IGKV4-1	2.46e-07	176	66	6	e4f33f6cd140dd4fa3002bcd65ac8005d27865d1
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-16 IGKV1D-8 IGKV4-1	2.54e-07	177	66	6	4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-16 IGKV1D-8 IGKV4-1	2.54e-07	177	66	6	d746122bf8d208c3aa4d156e8c12d0a0e555c6e5
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-16 IGKV1D-8 IGKV4-1	2.54e-07	177	66	6	fc40918825b7e1eb6861df59dfca944778a64b98
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-16 IGKV1D-8 IGKV4-1	2.72e-07	179	66	6	837ed81f18257f444eaeadc4fac89deedd4e3061
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-16 IGKV1D-8 IGKV4-1	2.72e-07	179	66	6	494febe77c6d4e6a2c6f0928bbf4c84b0301f188
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-16 IGKV1D-8 IGKV4-1	2.72e-07	179	66	6	b6ee4f41d8fb5f047b7bdd8489dda0a89fc6d43f
ToppCell	tumor_Lymph_Node_/_Brain-B_lymphocytes-Plasma_cells\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-43 IGKV4-1	2.89e-07	94	66	5	4b6623de5a517ebf5df865e0dcd615111622ad3e
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-16 IGKV1D-8 IGKV4-1	3.74e-07	189	66	6	5a42be62552d912d0abf68f00d75ac80bbd69f2c
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	NLRP11 IGKV1-16 IGKV1-6 IGKV1D-43 IGKV1D-8 IGKV4-1	4.23e-07	193	66	6	282b47dae6043eabb1e13d41d91c07b5ec21cd65
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-16 IGKV1D-8 IGKV4-1	4.49e-07	195	66	6	13f4ee21568fd747608412d33559d10561dbb3c8
ToppCell	Biopsy_Other_PF-Immune-Plasma_cells\|Biopsy_Other_PF / Sample group, Lineage and Cell type	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-16 IGKV1D-8 IGKV4-1	4.49e-07	195	66	6	d0305c6a68c9e361507b04db94f86873085d49b3
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-16 IGKV1D-8 IGKV4-1	4.63e-07	196	66	6	c38e7f533c619afe008de0e99042f7180c2da918
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLC6A3 SLC6A11 ATP13A5 LRP1B DNAH9	4.26e-06	162	66	5	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	356C-Fibroblasts-Fibroblast-D\|356C / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-5 TENM3 ITGA8 ADAMTS8 MGAT4C	4.80e-06	166	66	5	7286a37b2827f3747469ffd0d76cbe81116db7ee
ToppCell	390C-Lymphocytic-Plasma_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-6 IGKV1D-43 IGKV1D-16 IGKV1D-8 IGKV4-1	4.80e-06	166	66	5	4ba3711a02d3695b27f7cefd7c60e3be009f5bef
ToppCell	356C-Fibroblasts-Fibroblast-D-\|356C / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-5 TENM3 ITGA8 ADAMTS8 MGAT4C	4.80e-06	166	66	5	7c2eee0a4f45795a956acf936b85bdb35f1b1624
ToppCell	390C-Lymphocytic-Plasma_cell-\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-6 IGKV1D-43 IGKV1D-16 IGKV1D-8 IGKV4-1	4.80e-06	166	66	5	35f6ae2664935dda0d883b32a050ced843204f2d
ToppCell	Plasma_cells\|World / lung cells shred on cell class, cell subclass, sample id	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-8 IGKV4-1	5.86e-06	173	66	5	52a387e2a4694af61a9223a4c2ecf4e6f762c064
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-16 IGKV1-6 IGKV1D-43 IGKV1D-8 IGKV4-1	5.86e-06	173	66	5	7e6bfe85f60834f317941b70d6e0dc3bd527d293
ToppCell	Healthy-Plasmablast\|World / disease group, cell group and cell class	IGKV1-16 IGKV1-5 IGKV1D-16 IGKV1D-8 IGKV4-1	6.03e-06	174	66	5	6becb456d8f44a1224c6d42be78d4c8cdb51f199
ToppCell	3'_v3-bone_marrow-Lymphocytic_B_plasma-Plasma_cells\|bone_marrow / Manually curated celltypes from each tissue	NLRP11 IGKV1-16 IGKV1-5 ITGA8 IGKV4-1	6.20e-06	175	66	5	51301f3f44d3e88397f367cedd1e2abaa2be4c6f
ToppCell	COPD-Lymphoid-B_Plasma\|World / Disease state, Lineage and Cell class	IGKV1-16 IGKV1-5 IGKV1D-16 IGKV1D-8 IGKV4-1	6.20e-06	175	66	5	d73ee324479172501481b54967a0f3bd870fcf3a
ToppCell	Control-Lymphoid_P-Plasmablast\|Control / Disease group, lineage and cell class	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-16 IGKV4-1	6.37e-06	176	66	5	4b4416f342b732d2cc60133838728880326257d8
ToppCell	Control-Lymphoid_P\|Control / Disease group, lineage and cell class	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-16 IGKV4-1	6.37e-06	176	66	5	d895a6b295cd649273ff80ad7785a3e0ae4c728a
ToppCell	(2)_Plasma_cells\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	IGKV1-5 IGKV1-6 IGKV1D-16 IGKV1D-8 IGKV4-1	6.55e-06	177	66	5	ed3c936bb69f9bc7291b4f6cde1d204078117c48
ToppCell	Healthy-Plasmablast\|Healthy / disease group, cell group and cell class	IGKV1-16 IGKV1-5 IGKV1D-16 IGKV1D-8 IGKV4-1	6.55e-06	177	66	5	4ff75c609ac9edf7a94bda42eb7124c559e8b6aa
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-43 IGKV4-1	7.11e-06	180	66	5	cea079bc02e08c46600eed05ab9924ec90e1e3d3
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-43 IGKV4-1	7.30e-06	181	66	5	e47664a264a2c37390d1668ce04eef2e0172f4cb
ToppCell	Mild_COVID-19-B_cell\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-8 IGKV4-1	7.70e-06	183	66	5	dea119e2988e954475f557f0bbe12556a83e81a4
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-8 IGKV4-1	7.70e-06	183	66	5	cf5c98f451a568308c52da5c926543dd4836c6b2
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-16 IGKV4-1	7.91e-06	184	66	5	15f2c10101ccc8ed059520fc082ee42593dff269
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-16 IGKV4-1	7.91e-06	184	66	5	a90a58d9e319afa1cd572e4c2f516fadc42f56e5
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-8 IGKV4-1	8.12e-06	185	66	5	0fff2608f507e019ebb69c27e58fd5be3b049bef
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-8 IGKV4-1	8.12e-06	185	66	5	79edc1eeb7b5b9123961ac3ecf398ee68d9dddb9
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-5 IGKV1D-43 IGKV1D-16 IGKV1D-8 IGKV4-1	8.12e-06	185	66	5	08bc817908076734d66f2805cb954141f2cc5a18
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-5 IGKV1D-43 IGKV1D-16 IGKV1D-8 IGKV4-1	8.12e-06	185	66	5	1704a12153a9b107bf03ecccd1a036cf61334d7a
ToppCell	healthy_donor-Lymphocytic-Plasma_cell-IgA_Plasmablast\|healthy_donor / Disease condition, Lineage, Cell class and subclass	IGKV1-5 IGKV1-6 IGKV1D-43 IGKV1D-16 IGKV4-1	8.34e-06	186	66	5	e2c050ba02e1f84f0b7258dc92e7ff6ab349ff67
ToppCell	Mild_COVID-19-B_cell-B_cell\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-8 IGKV4-1	8.34e-06	186	66	5	855a5a00ba2aa1b5c63b8db56d026ddecc546050
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2G DYNC2H1 B4GALNT3 PFKP LRP1B	8.55e-06	187	66	5	f124d2c699b717b7c02a1a70493f515b83dc2f4c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2G DYNC2H1 B4GALNT3 PFKP LRP1B	9.01e-06	189	66	5	e32172ad09e93f6ac6ea2b92145b2b73003f7970
ToppCell	(2)_Fibroblasts-(22)_Fibro-3\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	GREB1L CACNA2D1 TENM3 CILP ITGA8	9.24e-06	190	66	5	3aed03b87ba2c8d479048c3ceef3ff5e38746c28
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	IGKV1-16 IGKV1-5 IGKV1-6 IGKV1D-8 IGKV4-1	9.24e-06	190	66	5	a21d0c574abf21e7cb865a21a48f29c92d055fbe
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GREB1L MGAM TENM3 PIK3C2G LRP1B	9.48e-06	191	66	5	3e828cffa24ded19f591a7ed6c1fe88ad57fdcac
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TENM3 PLEKHG3 JAG1 ITGA8 PFKP	9.48e-06	191	66	5	9431ffd6b758f756609d9057de2023596e22b5d4
ToppCell	renal_papilla_nuclei-Adult_normal_reference\|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	GREB1L MGAM CACNA2D1 TENM3 ITGA8	9.72e-06	192	66	5	6c106b91e46eabbe686a52a65a9c94ad9cbe9390
ToppCell	Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-5 IGKV1-6 ITGA8 IGKV1D-8 IGKV4-1	9.72e-06	192	66	5	ca4d8e540d9e6fa47ecf97648cbd5abfc7ab7f85
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GREB1L MGAM TENM3 PIK3C2G LRP1B	1.02e-05	194	66	5	04bfc555743f7d8821439d05ae442d15e9886c59
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GREB1L MGAM TENM3 PIK3C2G LRP1B	1.02e-05	194	66	5	69bff17df4a760ccf081cf52ff04af02c14f448d
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	TENM3 NPAS3 ITGA8 LRP1B MGAT4C	1.02e-05	194	66	5	85e00861c5068a27d0cf0ae677f420c8245baa9a
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-16 IGKV1-5 IGKV1D-16 IGKV1D-8 IGKV4-1	1.05e-05	195	66	5	2d18f08f33f3b261c77b8adf87d1a184cc6d7400
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A3 SLC6A11 ATP13A5 LRP1B	6.39e-05	145	66	4	96712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2G DYNC2H1 B4GALNT3 LRP1B	7.86e-05	153	66	4	9b6675ace8a83c8d446b722301d0ec4e6840f3fc
ToppCell	facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC41A2 DYNC2H1 JAG1 PFKP	7.86e-05	153	66	4	0ef7c45cdd854c79e527006034029767f8e108b2
ToppCell	PBMC-Control-cDC_2\|Control / Compartment, Disease Groups and Clusters	ZNF462 IGKV1-5 NBEAL1 IGKV4-1	7.86e-05	153	66	4	4ee37266b0054f276c7a73ab9220f681b9d74c71
ToppCell	tumor_Lymph_Node_/_Brain-B_lymphocytes-MALT_B_cells\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	IGKV1-16 IGKV1-5 IGKV1-6 IGKV4-1	9.13e-05	159	66	4	204e5a675f4684c9570c24c8d34bbf632fd8164a
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIK3C2G ATP13A5 LRP1B DNAH9	9.35e-05	160	66	4	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIK3C2G ATP13A5 LRP1B DNAH9	9.35e-05	160	66	4	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	368C-Lymphocytic-Plasma_cell-\|368C / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-5 IGKV1-6 IGKV1D-8 IGKV4-1	9.81e-05	162	66	4	c21a54310b239d999bbc9d8fb5e8fda16e0bc336
ToppCell	368C-Lymphocytic-Plasma_cell\|368C / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-5 IGKV1-6 IGKV1D-8 IGKV4-1	9.81e-05	162	66	4	f945688815229c8386cbcbf46deee7df316fa8d3
ToppCell	343B-Lymphocytic-Plasma_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	PTPRS ITGA8 IGKV1D-16 IGKV4-1	1.03e-04	164	66	4	cf62d34ce9dd220fe61748466c84fd70d9ba697c
ToppCell	343B-Lymphocytic-Plasma_cell-\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	PTPRS ITGA8 IGKV1D-16 IGKV4-1	1.03e-04	164	66	4	e00549bc8b3a5566f39031f39d7e698b0b107a7f
ToppCell	Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	GREB1L CACNA2D1 NPAS3 MGAT4C	1.03e-04	164	66	4	be49af6335f2505065cde2cb9800e4a5516811b1
ToppCell	367C-Lymphocytic-Plasma_cell-\|367C / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-5 IGKV1-6 IGKV1D-43 IGKV4-1	1.10e-04	167	66	4	f2185eb72f0137136f6d71af2a70168fded6c940
ToppCell	367C-Lymphocytic-Plasma_cell\|367C / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-5 IGKV1-6 IGKV1D-43 IGKV4-1	1.10e-04	167	66	4	5e768cf24699893e05d1bcb1c92dba2336943a64
ToppCell	BAL-Mild-Lymphocyte-B\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-16 IGKV1-5 IGKV1-6 IGKV4-1	1.15e-04	169	66	4	307571e57c3bfdf15f0fe1a8b36585e8e4f8a207
ToppCell	Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	GREB1L CACNA2D1 NPAS3 MGAT4C	1.15e-04	169	66	4	b6b5bb6408c1305a00719e1b88a5e1202081faf3
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIK3C2G ATP13A5 LRP1B DNAH9	1.15e-04	169	66	4	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell-B_activate-7\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-16 IGKV1-5 IGKV1-6 IGKV4-1	1.18e-04	170	66	4	ee2ee67d90ae4596de8ccd620e37c82cf51651d4
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-16 IGKV1-5 IGKV1-6 IGKV4-1	1.18e-04	170	66	4	d7ca0c6ce5d2b7de99346f87e07aa7fe728fa08a
ToppCell	-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	NLRP11 IGKV1-6 TRAV38-1 IGKV4-1	1.18e-04	170	66	4	601630644f09133ee4c5e64499460b55cf3e80a0
ToppCell	Control-Lymphoid-B_Plasma\|World / Disease state, Lineage and Cell class	IGKV1-5 ITGA8 IGKV1D-43 IGKV4-1	1.18e-04	170	66	4	fb05f49b7113470995b3c16683c54dc1a660b73a
ToppCell	BAL-Mild-Lymphocyte-B-B_cell\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-16 IGKV1-5 IGKV1-6 IGKV4-1	1.18e-04	170	66	4	52787f6d529c285d9f0c04cc022710ead5b89b3f
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell\|Adult / Lineage, Cell type, age group and donor	CACNA2D1 PLEKHG3 JAG1 ITGA8	1.24e-04	172	66	4	c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf
ToppCell	10x5'-Lung-Lymphocytic_B-Memory_B_cells\|Lung / Manually curated celltypes from each tissue	IGKV1-16 IGKV1-6 IGKV1D-8 IGKV4-1	1.24e-04	172	66	4	2cb2dc7cfd6db5a98a393b1a84c23abf3d692a53
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-5 IGKV1-6 IGKV1D-16 IGKV4-1	1.26e-04	173	66	4	0ca2169a275404118038c0489a48062879488765
ToppCell	10x5'-bone_marrow-Lymphocytic_B_plasma-Plasma_cells\|bone_marrow / Manually curated celltypes from each tissue	IGKV1-5 IGKV1-6 ITGA8 IGKV4-1	1.26e-04	173	66	4	300904fd35536a69be81d76fe33fe16544523ceb
ToppCell	10x5'-bone_marrow-Lymphocytic_B_plasma\|bone_marrow / Manually curated celltypes from each tissue	IGKV1-5 IGKV1-6 ITGA8 IGKV4-1	1.29e-04	174	66	4	b1931028cf80af5eff6da15d7f0196205f17926f
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TENM3 B4GALNT3 LRP1B CEMIP2	1.35e-04	176	66	4	0710689e66deba179b0a8038cdd56b4834984f12
ToppCell	IPF-Lymphoid-B_Plasma\|World / Disease state, Lineage and Cell class	IGKV1-5 IGKV1D-43 IGKV1D-8 IGKV4-1	1.35e-04	176	66	4	cc0cab6487df6867b529596ec94f55d31aa6ca36
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	IGKV1-16 IGKV1-5 IGKV1-6 IGKV4-1	1.38e-04	177	66	4	c2b0fb5921eea24d248d6e6ccb57c29b0832602c
Disease	asthma, response to diisocyanate	CACNA2D1 TENM3 DYNC2H1 MYLIP NPAS3 ITGA8 LRP1B	1.01e-06	261	60	7	EFO_0006995, MONDO_0004979
Disease	white matter microstructure measurement	CACNA2D1 SASH1 NBEAL1 CD28 JAG1 PSMD1 ERI1	1.41e-05	390	60	7	EFO_0005674
Disease	renal agenesis (is_implicated_in)	GREB1L ITGA8	2.43e-05	4	60	2	DOID:14766 (is_implicated_in)
Disease	glycogen storage disease (implicated_via_orthology)	PFKM PFKP	2.43e-05	4	60	2	DOID:2747 (implicated_via_orthology)
Disease	hepatocellular carcinoma (is_marker_for)	CEBPB JAG1 ANXA10 XPO1 LRP1B DNMT3A	3.38e-05	301	60	6	DOID:684 (is_marker_for)
Disease	Congenital absence of kidneys syndrome	GREB1L ITGA8	4.05e-05	5	60	2	C1609433
Disease	Peripheral T-Cell Lymphoma	CD28 DNMT3A	1.81e-04	10	60	2	C0079774
Disease	Facies	JAG1 DNMT3A	1.81e-04	10	60	2	C0282631
Disease	thyroid stimulating hormone measurement	SASH1 PTPRS ITGA8 B4GALNT3 ERI1	5.08e-04	323	60	5	EFO_0004748
Disease	response to radiation, Urinary retention	PTPRS LRP1B	5.42e-04	17	60	2	GO_0009314, HP_0000016
Disease	feeling nervous measurement	MGAM CACNA2D1 AREL1	7.50e-04	87	60	3	EFO_0009597
Disease	Headache, HbA1c measurement	NBEAL1 PFKM	8.33e-04	21	60	2	EFO_0004541, HP_0002315
Disease	disease of metabolism (implicated_via_orthology)	PFKM PFKP	8.33e-04	21	60	2	DOID:0014667 (implicated_via_orthology)
Disease	Granulomatous Slack Skin	CD28 DNMT3A	9.15e-04	22	60	2	C0376407
Disease	Lymphoma, T-Cell, Cutaneous	CD28 DNMT3A	1.00e-03	23	60	2	C0079773
Disease	corpus callosum volume measurement	CACNA2D1 JAG1 XPO1	1.12e-03	100	60	3	EFO_0010299
Disease	Sezary Syndrome	CD28 DNMT3A	1.38e-03	27	60	2	C0036920
Disease	lumbar disc degeneration	DYNC2H1 PFKP	1.49e-03	28	60	2	EFO_0004994
Disease	cysteine-rich with EGF-like domain protein 1 measurement	SLC6A11 SETD5	1.94e-03	32	60	2	EFO_0021870

Protein segments in the cluster

Peptide	Gene	Start	Entry
NFADSYYDYICIIDF	ERI1	121	Q8IV48
YCEVYQYSECFLANQ	ATP13A5	1001	Q4VNC0
YCLQYSNNLQEDIYS	ANXA10	131	Q9UJ72
AYDNAVNLSCKYSYN	CD28	31	P10747
YQYDDDGYQSYCTIC	DNMT3A	526	Q9Y6K1
KCFYQENAYYQDRFS	B4GALNT3	391	Q6L9W6
SFREQQCEKYNAYNY	ADAMTS8	586	Q9UP79
CFDECNNQLPVYYTY	AASDH	21	Q4L235
NQNTYDDIAQDFKYY	DNAI1	291	Q9UI46
IANNALYNSADYSYS	ARMCX4	2061	Q5H9R4
AAVEALNVFYYCSYE	NBEAL1	2231	Q6ZS30
YQLINVYCNSFYADF	PIK3C2G	491	O75747
YLWFYRFYCNNENCS	PIK3C2G	676	O75747
YAFLLNFCANTSDYY	MGAT4C	206	Q9UBM8
VFEDYLYATNSDNYN	LRP1B	421	Q9NZR2
YDSTSYYSANNLNVF	NLRP11	136	P59045
EQRFESYYNYCNLFN	EIF3L	151	Q9Y262
SYYNYCNLFNYILNA	EIF3L	156	Q9Y262
QPEDFATYYCQQYYS	IGKV1D-43	101	A0A0B4J1Z2
NSNYNAETYASYFSA	METTL14	366	Q9HCE5
CYFVNDLYSVSDVQY	MGAM	996	O43451
AEYSNCGENEYYNQT	EDAR	26	Q9UNE0
QSEDFATYYCQQYYS	IGKV1D-8	101	A0A087WSZ0
YLAAYFIAYFNSCLN	GPR50	276	Q13585
CNENYTTDFIFNLYS	PFKM	631	P08237
CSENYTTDFIYQLYS	PFKP	641	Q01813
YNQNTAKYNYEELCA	MYLIP	131	Q8WY64
TQNVQYDFNRYFCED	GREB1L	1701	Q9C091
CYVAIQNFSAYAEFS	ITGA8	171	P53708
EDEYQFCYQAALEYL	PTPRS	1926	Q13332
DSEFQYTYEYQGNAS	DYNC2H1	1646	Q8NCM8
VYAFNKSYDYQSVCE	CACNA2D1	891	P54289
VANFYYEADCLAAAY	CEBPB	26	P17676
DCYSDERYQCYNQEQ	CEP350	2581	Q5VT06
YFEAYLYNATNCSST	AREL1	296	O15033
EFCSYLQYLEYLSQN	PRMT5	276	O14744
SCYAENQCQFFDYDT	CEMIP2	501	Q9UHN6
AAAGQSYSYYCDQNF	CFHR4	46	Q92496
NTYFAEYWYQAQCCQ	LY6G5B	86	Q8NDX9
TELYINYDCDYYCSN	GBF1	536	Q92538
NYDCDYYCSNLFEEL	GBF1	541	Q92538
QPDDFATYYCQQYNS	IGKV1-5	101	P01602
QPEDFATYYCLQDYN	IGKV1-6	101	A0A0C4DH72
QPEDFATYYCQQYNS	IGKV1-16	101	P04430
AEDVAVYYCQQYYST	IGKV4-1	106	P06312
LAYACVYSFYSQDAE	CUL9	2346	Q8IWT3
CDAQFLYSYEYLGNT	DNAH9	1826	Q9NYC9
SYFYNYPAVCEFLQN	PPP3CB	266	P16298
DSYYQDNCANITFTF	JAG1	951	P78504
MFDSSQYPYNCFNYD	FOXL3	1	A0A1W2PRP0
DYSYNQFSTYGDANA	PRCC	341	Q92733
EFDIYTQYCNNYPNS	PLEKHG3	176	A1L390
YQICFDLYESASQQF	PSMD1	246	Q99460
TIAFDYEYSNCNYKV	SETD5	386	Q9C0A6
ASSSCSQKYDDYANY	SLC41A2	101	Q96JW4
SQKYDDYANYNYCDG	SLC41A2	106	Q96JW4
YDGIYCESTYQNLQA	NPAS3	36	Q8IXF0
DCFQNATNSFYYDVG	CILP	416	O75339
YQFYCLFSQQTLYDS	ATP11B	896	Q9Y2G3
QEEAAAQSFYQTYFC	XPO1	906	O14980
AFSSYNKFTNNCYRD	SLC6A3	331	Q01959
DLAQQYADYYNTCFS	SASH1	61	O94885
GSYNNYNNNCYRDCI	SLC6A11	321	P48066
YLYNFSYSNDNDITA	TENM3	1541	Q9P273
YQCQYCEYRSADSSN	ZFX	576	P17010
CYIDYTNFEDLQQHY	ZNF462	891	Q96JM2
NNTYYQECLFYLHNY	ZFYVE26	2156	Q68DK2
LSCTYDTSENNYYLF	TRAV38-1	41	A0A0B4J264
QPEDFATYYCQQYNS	IGKV1D-16	101	P01601
STDDYFYINGQYQFD	N4BP2	471	Q86UW6